A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance

QR Code

A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance

Despite significant advances in the treatment of hepatitis C virus (HCV) infection, the need to develop preventative vaccines remains. Identification of the best vaccine candidates and evaluation of their performance in preclinical and clinical development will require appropriate neutralization ass...

Full description

Bibliographic Details
Main Authors:	Urbanowicz, Richard A., McClure, Patrick, Brown, Richard J.P., Tsoleridis, Theocharis, Persson, Mats A.A., Krey, Thomas, Irving, William L., Ball, Jonathan K., Tarr, Alexander W.
Format:	Article
Published:	American Society for Microbiology 2016
Online Access:	https://eprints.nottingham.ac.uk/34388/

Similar Items

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
by: Mesalam, Ahmed Atef, et al.
Published: (2018)

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the Hepatitis C virus E2 protein confer noninterfering, additive neutralization
by: Tarr, Alexander, W., et al.
Published: (2012)

Novel functional hepatitis C virus glycoprotein isolates identified using an optimised viral pseudotype entry assay
by: Urbanowicz, Richard A., et al.
Published: (2016)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
by: Desombere, Isabelle, et al.
Published: (2017)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitus C virus E2 protein confer noninterfering, additive neutralization
by: Tarr, Alexander W., et al.
Published: (2012)

Flexible and rapid construction of viral chimeras applied to Hepatitis C Virus
by: McClure, Patrick C., et al.
Published: (2016)

Monoclonal antibodies against the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain AF2240
by: Lee, L. K., et al.
Published: (2007)

The Regulation of Peptide Mimotope/Epitope Recognition by Monoclonal Antibodies
by: Smith, Richard Gary
Published: (2002)

Probing the interaction of Hepatitis C virus glycoproteins with putative receptors and neutralising antibodies
by: Mirza, Deeman
Published: (2012)

Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin
by: Tawar, Rajiv G., et al.
Published: (2016)

Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of Fc?RIIa and induce GPVI ectodomain shedding
by: Al-Tamimi, M., et al.
Published: (2009)

Generation of a Panel of Monoclonal Antibodies Against the Haemagglutinin-Neuraminidase Glycoprotein of Newcastle Disease Virus Strain Af2240
by: Lee, Lin Kiat
Published: (2005)

Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)

Use of short-tandem repeat (STR) fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies
by: Edwards, Victoria C., et al.
Published: (2014)

Identification of novel alphacoronaviruses in European wildlife
by: Tsoleridis, Theocharis
Published: (2018)

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals
by: Ferns, R. Bridget, et al.
Published: (2016)

Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’
by: Watts, G., et al.
Published: (2018)

Characterisation of anti-glycan monoclonal antibodies
by: Noble, Philip W.
Published: (2011)

Development of techniques for the isolation and characterisation of human monoclonal antibodies from Hepatitis C virus infected individuals
by: Edwards, Victoria C.
Published: (2012)

Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host
by: Brown, Richard J.P., et al.
Published: (2012)

The generation and characterisation of anti-glycan monoclonal antibodies
by: Chua, Jia Xin
Published: (2017)

Predicting response to monoclonal antibody in severe asthma
by: Pang, Yik Lam
Published: (2022)

Generation and validation of Aspergillus fumigatus monoclonal antibodies
by: Jafarlou, Mahdi
Published: (2009)

Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 envelope glycoprotein trimers on neutralizing antibody induction
by: Crooks, Ema T, et al.
Published: (2017)

Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12
by: Sterjovski, J., et al.
Published: (2012)

Production and evaluation of monoclonal antibody against Strongyloides ratti
by: Aliyu, Mahmuda
Published: (2017)

Monoclonal antibodies specific to heat-treated porcine blood
by: Raja Nhari, Raja Mohd Hafidz, et al.
Published: (2016)

Development Of An Immune Tuberculosis Antibody Library: Monoclonal Antibody Generation For a-Crystalline Antigen
by: Hamidon, Nurul Hamizah
Published: (2017)

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules
by: Rees, Jennifer, et al.
Published: (2016)

Monoclonal antibodies: a review of therapeutic applications and future prospects
by: Mahmuda, Aliyu, et al.
Published: (2017)

Production And Characterization Of Recombinant Monoclonal Antibodies Against Toxocara Antigens
by: Baharudeen, Zamrina Mohd
Published: (2023)

A mouse IgM monoclonal antibody recognized breast and colon cancer.
by: A. Bakar, Ainul Fajariah, et al.
Published: (2009)

Experimental design of a novel target to isolate HCV monoclonal antibodies
by: Brice, Sophie
Published: (2014)

Production and Scale-Up of a Monoclonal Antibody Against 17-Hydroxyprogesterone
by: Chua, Gek Kee, et al.
Published: (2013)

Simulation study of monoclonal antibody production using superpro, upstream process
by: Mohd Shamsul, Husin
Published: (2009)

Expression Of Monoclonal Antibody IBMR3 Antigen In Breast Cancer Tissue
by: Othman, Ekhlas Qaid Gazem
Published: (2016)

Expression Of Monoclonal Antibody IBMR3 Antigen In Breast Cancer Tissue
by: Gazem, Ekhlas Qaid
Published: (2016)

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb
by: Paciello, Rolando, et al.
Published: (2016)